Raleigh pharma firm BDSI paying millions to acquire migraine treatment
BioDelivery Sciences International is paying millions to acquire rights in the U.S. and Canada for an FDA-approved migraine treatment from Dr. Reddy’s Laboratories.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
